Alfa Cytology offers specialized radiolabeling and antibody-radionuclide conjugate development to advance radiopharmaceutical and nuclear medicine research.

ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.

In this free webinar, learn about conjugation methods, applications and clinical progress of small nucleic acid drug conjugates. Attendees will gain insight into the characterization of conjugated ...